ATYR

aTYR PHARMA INC

Healthcare · Biotechnology

$223.34 sample

+1.11 (+0.50%) 1D

Market cap

$367.0B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-26

Alerts

8

Price$223.34 +15.26% 3M daily closessample

224.18192.83

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: Chief Executive Officer
Sep 16INSInsider sell: EVP, Operations
Sep 07INSInsider sell: Chief Executive Officer
Aug 31INSInsider sell: Director
Aug 26SECDEF 14A filed
Aug 20INSInsider sell: Director
Aug 11INSInsider sell: Director
Jul 31INSInsider sell: Chief Financial Officer

Sign up to see the real ATYR record →

Company facts

SEC EDGAR registration

Name: aTYR PHARMA INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +31sample, -100 to +100
Reporting currency: USD

Who is positioning in ATYR

sample

Insiders: 30 insider transactions over 90 days, net selling, $157.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 41 funds hold $5.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.9B +21.5% y/y

Q4 2024Q3 2026

Inventory$12.8B +17.7% y/y

Q4 2024Q3 2026

Accounts receivable$9.4B +6.0% y/y

Q4 2024Q3 2026

Total debt$25.0B +15.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $212.6B +0.2% 3M
Sample peer B: $193.5B +3.3% 3M
Sample peer C: $63.0B +0.7% 3M
Sample peer D: $76.4B -4.5% 3M
Sample peer E: $285.0B +4.0% 3M